Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novo Nordisk A/S ADR buy TD Cowen

Start price
€48.60
03.02.26 / 50%
Target price
-
03.02.27
Performance (%)
-14.09%
Price
€41.75
22:26
Summary
This prediction is currently active. The price of Novo Nordisk A/S ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.09%. This prediction currently runs until 03.02.27. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this prediction
Performance without dividends (%)
Name 1w
Novo Nordisk A/S ADR 1.091%
iShares Core DAX® 0.193%
iShares Nasdaq 100 -1.353%
iShares Nikkei 225® -0.426%
iShares S&P 500 -1.008%

Comments by TD_Cowen for this prediction

In the thread Novo Nordisk A/S ADR diskutieren

Novo Nordisk A/S (NYSE:NVO) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for NVO provided by MarketBeat

Stopped prediction by TD_Cowen for Novo Nordisk A/S ADR

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€47.20
19.08.25
€60.08
19.08.26
-11.55%
22:26

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€93.00
04.12.23
€106.28
04.12.24
11.83%
05.12.24